GRN and neurodegenerative disease: Similarly to previous tested PGRN plasma assays, in this study, comparing PGRN levels between different neurodegenerative diseases show significant distinction from GRN mutation and non-GRN mutation carriers, without any differences from symptomatic to non-symptomatic GRN mutation carriers [20, 22].